Harrow (HROW) EBITDA (2010 - 2026)

Harrow's EBITDA history runs 17 years deep, the most recent figure standing at -$22.1 million for Q1 2026.

• On a quarterly basis, EBITDA fell 96.58% year-over-year to -$22.1 million in Q1 2026; TTM through Mar 2026 was $19.7 million, a 335.3% increase from a year earlier, with the FY2025 full-year figure at $30.5 million, up 245.9% from the prior year.
• EBITDA retreated to -$22.1 million in Q1 2026 per HROW's latest filing, from $15.6 million in the prior quarter.
• Across five years, EBITDA topped out at $15.6 million in Q4 2025 and bottomed at -$22.1 million in Q1 2026.
• The 5-year median for EBITDA is $1.5 million (2024), against an average of $1.2 million.
• Across the five-year window, EBITDA jumped 1955.32% in 2023 and slumped 672.56% in 2024, its largest moves.
• Year by year, EBITDA stood at -$1.8 million in 2022, then tumbled by 174.18% to -$4.9 million in 2023, then surged by 364.59% to $12.9 million in 2024, then increased by 20.87% to $15.6 million in 2025, then sank by 241.62% to -$22.1 million in 2026.
• Per Business Quant, the three latest HROW EBITDA figures stand at -$22.1 million (Q1 2026), $15.6 million (Q4 2025), and $14.7 million (Q3 2025).